3 ms·
Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts guidance
- TMWNN 1y agoEdited by me from "Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance"
- joezydeco 1y agoPress release omits the fact that NN forgot to renew the Canadian patent in 2019 and the drug goes generic north of the border in 2026. https://www.science.org/content/blog-post/novo-nordisk-s-canadian-mistake https://www.science.org/content/blog-post/novo-nordisk-s-can...
- TMWNN 1y agoNot a mistake. fox in the comments explains what Novo Nordisk was thinking at the time. The PMPRB he mentions is <https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Review_Board https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Revie...>